Technical Analysis for BPTH - Bio-Path Holdings Inc

Grade Last Price % Change Price Change
grade D 14.54 -0.82% -0.12
BPTH closed down 0.82 percent on Friday, May 24, 2019, on 9 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
15 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical BPTH trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -0.82%
Gapped Down Weakness -0.82%
Oversold Stochastic Weakness -0.82%
Narrow Range Bar Range Contraction -2.09%
NR7 Range Contraction -2.09%
BB Squeeze Ended Range Expansion -2.09%

Older signals for BPTH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers. The company's other drug candidate, Liposomal Bcl-2, is ready for the clinic where it would be evaluated in lymphoma and solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Houston, Texas.
Biotechnology Solid Tumors Breast Cancer Lymphoma Cell Biology Therapeutic Products Oncogenes Apoptosis Blood Cancers
Is BPTH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 16 Bio-Path files for $125M mixed shelf; shares down 7% after hours
May 16 Edited Transcript of BPTH earnings conference call or presentation 16-May-19 12:30pm GMT
May 16 Bio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q1 2019 Results - Earnings Call Transcript
May 16 WIX and FTCH among premarket losers
May 16 Bio-Path: 1Q Earnings Snapshot
May 16 Bio-Path Holdings Reports First Quarter 2019 Financial Results
May 16 Bio-Path reports Q1 results
May 15 Easy Come, Easy Go: How Bio-Path Holdings (NASDAQ:BPTH) Shareholders Torched 97% Of Their Cash
May 10 Bio-Path Holdings to Announce First Quarter 2019 Financial Results on May 16, 2019
Apr 22 54 Biggest Movers From Thursday
See more BPTH news...
Indicators
Indicator Value
52 Week High 73.52
52 Week Low 1.61
Average Volume 681,052
200-Day Moving Average 13.5055
50-Day Moving Average 18.3048
20-Day Moving Average 16.2985
10-Day Moving Average 15.703
Average True Range 1.4069
ADX 19.24
+DI 25.158
-DI 24.4187
Chandelier Exit (Long, 3 ATRs ) 14.7793
Chandelier Exit (Short, 3 ATRs ) 18.5207
Upper Bollinger Band 18.5692
Lower Bollinger Band 14.0278
Percent B (%b) 0.11
BandWidth 27.863914
MACD Line -0.7848
MACD Signal Line -0.5822
MACD Histogram -0.2025
Fundamentals Value
Market Cap 1.45 Billion
Num Shares 100 Million
EPS -0.07
Price-to-Earnings (P/E) Ratio -207.71
Price-to-Sales 3232.58
Price-to-Book 4.77
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.40
Resistance 3 (R3) 15.41 15.14 15.25
Resistance 2 (R2) 15.14 14.92 15.13 15.20
Resistance 1 (R1) 14.84 14.79 14.71 14.83 15.16
Pivot Point 14.57 14.57 14.50 14.56 14.57
Support 1 (S1) 14.27 14.35 14.14 14.26 13.92
Support 2 (S2) 14.00 14.22 13.99 13.88
Support 3 (S3) 13.70 14.00 13.83
Support 4 (S4) 13.69